Anti-Mullerian hormone (AMH): what do we still need to know? (Q45972242)

18 December 2017

title

Anti-Mullerian hormone (AMH): what do we still need to know? (English)

1 reference

18 December 2017

author name string

A La Marca

1

1 reference

18 December 2017

F J Broekmans

2

1 reference

18 December 2017

A Volpe

3

1 reference

18 December 2017

B C Fauser

4

1 reference

18 December 2017

N S Macklon

5

1 reference

18 December 2017

ESHRE Special Interest Group for Reproductive Endocrinology--AMH Round Table

6

1 reference

18 December 2017

language of work or name

English

0 references

publication date

11 June 2009

1 reference

18 December 2017

published in

Human Reproduction

1 reference

18 December 2017

volume

24

1 reference

18 December 2017

page(s)

2264-2275

1 reference

18 December 2017

issue

9

1 reference

18 December 2017

Estradiol and regulation of anti-Müllerian hormone, inhibin-A, and inhibin-B secretion: analysis of small antral and preovulatory human follicles' fluid.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Serum anti-mullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

A systematic review of tests predicting ovarian reserve and IVF outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Anti-Müllerian hormone and ovarian dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Anti-Müllerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Antimüllerian hormone serum levels: a putative marker for ovarian aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Müllerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Early follicular antimüllerian hormone as an indicator of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Dynamics of FSH-induced follicular growth in subfertile women: relationship with age, insulin resistance, oocyte yield and anti-Mullerian hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Relevance of anti-Mullerian hormone measurement in a routine IVF program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Anti-Müllerian hormone levels in serum from human foetuses and children: pattern and clinical interest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Mullerian inhibiting substance inhibits ovarian cell growth through an Rb-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Müllerian inhibiting substance gene expression in the cycling rat ovary correlates with recruited or graafian follicle selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Anti-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Anti-Müllerian hormone concentrations in maternal serum during pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Serum anti-Mullerian hormone throughout the human menstrual cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Anti-Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Mullerian inhibiting substance in humans: normal levels from infancy to adulthood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Anti-müllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Predictors of ovarian reserve in young women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Initial and Cyclic Recruitment of Ovarian Follicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Serum anti-Müllerian hormone expression in women with premature ovarian failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Antimüllerian hormone and pituitary gland activity after prolonged down-regulation with goserelin acetate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Oocyte regulation of anti-Müllerian hormone expression in granulosa cells during ovarian follicle development in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Early metabolic derangements in daughters of women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Anti-Müllerian hormone: its role in follicular growth initiation and survival and as an ovarian reserve marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Anti-mullerian hormone as a marker of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Relationship of serum antimüllerian hormone concentration to age at menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Predictors of recovery of ovarian function during weight gain in anorexia nervosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Anti-Müllerian hormone and folliculogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Increased oocyte degeneration and follicular atresia during the estrous cycle in anti-Müllerian hormone null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Formation and early development of follicles in the polycystic ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP210

21 January 2018

Identifiers

DOI

10.1093/HUMREP/DEP210

1 reference

18 December 2017

PubMed ID

19520713

1 reference

18 December 2017